| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 80, 729-734, Copyright © 1995 by Endocrine Society
ARTICLES |
SJ Silverberg, F Gartenberg, TP Jacobs, E Shane, E Siris, RB Staron, DJ McMahon and JP Bilezikian
Department of Medicine, Columbia University, College of Physicians and Surgeons, New York, New York 10032.
Skeletal involvement in primary hyperparathyroidism is characterized by preferential loss of cortical bone, whereas cancellous bone is relatively spared. Little data are available concerning changes in bone density, particularly at sites containing more cancellous bone, after successful parathyroidectomy. Most patients with primary hyperparathyroidism are asymptomatic, but approximately 50% meet one or more criteria for surgery. In a prospective study of 34 patients who met one or more such criteria, bone density rose at all skeletal sites (lumbar spine, femoral neck, and the radius) in the 4 yr after surgery. The lumbar spine, with most cancellous bone, showed a rapid (mean +/- SE, yr 1, 8.2 +/- 2.0%; P < 0.005) and sustained (yr 4, 12.8 +/- 2.8%; P < 0.001) rise. Post-menopausal patients were similar (by yr 4, 12.5 +/- 2.7%; P < 0.005). At the femoral neck, with intermediate cancellous and cortical composition, a similar increase was noted (12.7 +/- 3.8% by yr 4; P < 0.01). The distal radius, containing mostly cortical bone, rose modestly (4.0 +/- 1.5% by yr 3; P < 0.05), except in patients with lowest preoperative bone density, where the increase was marked (12.3 +/- 2.6% by yr 3; P < 0.05). In patients meeting surgical guidelines, parathyroidectomy is associated with improved bone mineral density.
This article has been cited by other articles:
![]() |
A. Bhansali, G Shanmugasundar, S. K Bhadada, R. Walia, and P Ravikumar Worsening of bone disease after curative surgery in primary hyperparathyroidism BMJ Case Reports, June 8, 2009; 2009(jun08_2): bcr1220081357 - bcr1220081357. [Abstract] [Full Text] |
||||
![]() |
H. Kaji, M. Yamauchi, R. Nomura, and T. Sugimoto Improved Peripheral Cortical Bone Geometry after Surgical Treatment of Primary Hyperparathyroidism in Postmenopausal Women J. Clin. Endocrinol. Metab., August 1, 2008; 93(8): 3045 - 3050. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Rudser, I. H. de Boer, A. Dooley, B. Young, and B. Kestenbaum Fracture Risk after Parathyroidectomy among Chronic Hemodialysis Patients J. Am. Soc. Nephrol., August 1, 2007; 18(8): 2401 - 2407. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Grey, J. Lucas, A. Horne, G. Gamble, J. S. Davidson, and I. R. Reid Vitamin D Repletion in Patients with Primary Hyperparathyroidism and Coexistent Vitamin D Insufficiency J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2122 - 2126. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Rao, E. R. Phillips, G. W. Divine, and G. B. Talpos Randomized Controlled Clinical Trial of Surgery Versus No Surgery in Patients with Mild Asymptomatic Primary Hyperparathyroidism J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5415 - 5422. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Khan, J. P. Bilezikian, A. W. C. Kung, M. M. Ahmed, S. J. Dubois, A. Y. Y. Ho, D. Schussheim, M. R. Rubin, A. M. Shaikh, S. J. Silverberg, et al. Alendronate in Primary Hyperparathyroidism: A Double-Blind, Randomized, Placebo-Controlled Trial J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3319 - 3325. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Silverberg and J. P. Bilezikian "Incipient" Primary Hyperparathyroidism: A "Forme Fruste" of an Old Disease J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5348 - 5352. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Chow, W. B. Chan, J. K. Y. Li, N. N. Chan, M. H. M. Chan, G. T. C. Ko, K. W. Lo, and C. S. Cockram Oral Alendronate Increases Bone Mineral Density in Postmenopausal Women with Primary Hyperparathyroidism J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 581 - 587. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Mittendorf and C. R. McHenry Persistent Parathyroid Hormone Elevation Following Curative Parathyroidectomy for Primary Hyperparathyroidism Arch Otolaryngol Head Neck Surg, March 1, 2002; 128(3): 275 - 279. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. F. Nemeth, E. G. Delmar, W. L. Heaton, M. A. Miller, L. D. Lambert, R. L. Conklin, M. Gowen, J. G. Gleason, P. K. Bhatnagar, and J. Fox Calcilytic Compounds: Potent and Selective Ca2+ Receptor Antagonists That Stimulate Secretion of Parathyroid Hormone J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 323 - 331. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-F. Chou, J.-B. Chen, C.-H. Lee, S.-H. Chen, and S.-M. Sheen-Chen Parathyroidectomy Can Improve Bone Mineral Density in Patients With Symptomatic Secondary Hyperparathyroidism Arch Surg, September 1, 2001; 136(9): 1064 - 1068. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Kantorovich, M. A. Gacad, L. L. Seeger, and J. S. Adams Bone Mineral Density Increases with Vitamin D Repletion in Patients with Coexistent Vitamin D Insufficiency and Primary Hyperparathyroidism J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3541 - 3543. [Abstract] [Full Text] |
||||
![]() |
P. Vestergaard, C. L Mollerup, V. G. Frøkjær, P. Christiansen, M. Blichert-Toft, and L. Mosekilde Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism BMJ, September 9, 2000; 321(7261): 598 - 602. [Abstract] [Full Text] |
||||
![]() |
B. J. Orr-Walker, M. C. Evans, J. M. Clearwater, A. Horne, A. B. Grey, and I. R. Reid Effects of Hormone Replacement Therapy on Bone Mineral Density in Postmenopausal Women With Primary Hyperparathyroidism: Four-Year Follow-up and Comparison With Healthy Postmenopausal Women Arch Intern Med, July 24, 2000; 160(14): 2161 - 2166. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Nakaoka, T. Sugimoto, T. Kobayashi, T. Yamaguchi, A. Kobayashi, and K. Chihara Prediction of Bone Mass Change after Parathyroidectomy in Patients with Primary Hyperparathyroidism J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1901 - 1907. [Abstract] [Full Text] |
||||
![]() |
S. J. Silverberg, E. Shane, T. P. Jacobs, E. Siris, and J. P. Bilezikian A 10-Year Prospective Study of Primary Hyperparathyroidism with or without Parathyroid Surgery N. Engl. J. Med., October 21, 1999; 341(17): 1249 - 1255. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Burgess, R. David, T. M. Greenaway, V. Parameswaran, and J. J. Shepherd Osteoporosis in Multiple Endocrine Neoplasia Type 1: Severity, Clinical Significance, Relationship to Primary Hyperparathyroidism, and Response to Parathyroidectomy Arch Surg, October 1, 1999; 134(10): 1119 - 1123. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Adams, V. Kantorovich, C. Wu, M. Javanbakht, and B. W. Hollis Resolution of Vitamin D Insufficiency in Osteopenic Patients Results in Rapid Recovery of Bone Mineral Density J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2729 - 2730. [Abstract] [Full Text] |
||||
![]() |
N. A. Tritos and P. Hartzband Rapid Improvement of Osteoporosis Following Parathyroidectomy in a Premenopausal Woman With Acute Primary Hyperparathyroidism Arch Intern Med, July 12, 1999; 159(13): 1495 - 1498. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. G. Bone Who Needs Parathyroid Surgery? The Case for Parathyroidectomy in Nonclassical Primary Hyperparathyroidismb J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2278 - 2282. [Full Text] |
||||
![]() |
K. K. Miller and A. Klibanski Amenorrheic Bone Loss J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 1775 - 1783. [Full Text] |
||||
![]() |
D. W. Dempster, M. Parisien, S. J. Silverberg, X.-G. Liang, M. Schnitzer, V. Shen, E. Shane, D. B. Kimmel, R. Recker, R. Lindsay, et al. On the Mechanism of Cancellous Bone Preservation in Postmenopausal Women with Mild Primary Hyperparathyroidism J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1562 - 1566. [Abstract] [Full Text] |
||||
![]() |
J. S. Adams, C. F. Song, and V. Kantorovich Rapid Recovery of Bone Mass in Hypercalciuric, Osteoporotic Men Treated with Hydrochlorothiazide Ann Intern Med, April 20, 1999; 130(8): 658 - 660. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Finkelstein and A. L. Arnold Increases in Bone Mineral Density after Discontinuation of Daily Human Parathyroid Hormone and Gonadotropin-Releasing Hormone Analog Administration in Women with Endometriosis J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1214 - 1219. [Abstract] [Full Text] |
||||
![]() |
Y. Duan, V. De Luca, and E. Seeman Parathyroid Hormone Deficiency and Excess: Similar Effects on Trabecular Bone But Differing Effects on Cortical Bone J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 718 - 722. [Abstract] [Full Text] |
||||
![]() |
M. Abdelhadi and J. Nordenström Bone Mineral Recovery after Parathyroidectomy in Patients with Primary and Renal Hyperparathyroidism J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 3845 - 3851. [Abstract] [Full Text] |
||||
![]() |
G. W. Maier, M. E. Kreis, W. Renn, P. L. Pereira, H. U. Häring, and H. D. Becker Parathyroid Hormone after Adenectomy for Primary Hyperparathyroidism. A Study of Peptide Hormone Elimination Kinetics in Humans J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 3852 - 3856. [Abstract] [Full Text] |
||||
![]() |
J. A. Sosa, N. R. Powe, M. A. Levine, R. Udelsman, and M. A. Zeiger Thresholds for Surgery and Surgical Outcomes for Patients with Primary Hyperparathyroidism: A National Survey of Endocrine Surgeons J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2658 - 2665. [Abstract] [Full Text] |
||||
![]() |
H. Plotkin, C. Gundberg, M. Mitnick, and A. F. Stewart Dissociation of Bone Formation from Resorption during 2-Week Treatment with Human Parathyroid Hormone-Related Peptide-(1-36) in Humans: Potential as an Anabolic Therapy for Osteoporosis J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2786 - 2791. [Abstract] [Full Text] |
||||
![]() |
C. A. M. Kulak, C. Bandeira, D. Voss, S. M. Sobieszczyk, S. J. Silverberg, F. Bandeira, and J. P. Bilezikian Marked Improvement in Bone Mass after Parathyroidectomy in Osteitis Fibrosa Cystica J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 732 - 735. [Full Text] |
||||
![]() |
A. Siddiqi, J. M. Burrin, K. Noonan, I. James, D. F. Wood, C. P. Price, and J. P. Monson A Longitudinal Study of Markers of Bone Turnover in Graves' Disease and Their Value in Predicting Bone Mineral Density J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 753 - 759. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Irvin III, G. Sfakianakis, L. Yeung, G. T. Deriso, L. M. Fishman, A. S. Molinari, and J. N. Foss Ambulatory Parathyroidectomy for Primary Hyperparathyroidism Arch Surg, October 1, 1996; 131(10): 1074 - 1078. [Abstract] [PDF] |
||||
![]() |
N. B. Watts and L. S. Blevins Jr Endocrinology JAMA, June 19, 1996; 275(23): 1806 - 1807. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |